Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
A better understanding of multimolecular interactions involved in tumor dissemination is required to identify new effective therapies for advanced prostate cancer (PCa). Several groups investigated protein-glycan interactions as critical factors for crosstalk between prostate tumors and their microe...
Saved in:
Main Authors: | Diego J. Laderach, Lucas Gentilini, Felipe M. Jaworski, Daniel Compagno |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Prostate Cancer |
Online Access: | http://dx.doi.org/10.1155/2013/519436 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities
by: Ignacio M. Seropian, et al.
Published: (2018-01-01) -
Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
by: Daniela Maria Tanase, et al.
Published: (2019-01-01) -
Galectin-3 Is a Potential Mediator for Atherosclerosis
by: Ziyu Gao, et al.
Published: (2020-01-01) -
GPX8 as a Novel Prognostic Factor and Potential Therapeutic Target in Primary Glioma
by: Zhao-shou Yang, et al.
Published: (2022-01-01) -
Galectin-3: A Novel Marker for the Prediction of Stroke Incidence and Clinical Prognosis
by: Ahmed Sayed, et al.
Published: (2022-01-01)